FDA Hints At Possible 510(k) Tweaks At Public Meeting

FDA is considering changing how predicate devices are selected for 510(k) submissions and beefing up its post-market authorities for 510(k)-cleared products, agency reps suggested at a Feb. 18 public meeting

More from Archive

More from Medtech Insight